Skip to main content
Log in

Modifying provider behavior

A low-tech approach to pharmaceutical ordering

  • Brief Reports
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

OBJECTIVE: To determine if a clinically structured, paperbased prescription form can modify pharmaceutical prescribing behavior without restricting physician freedom to select the most appropriate medication for an individual patient.

DESIGN: Uncontrolled, nonrandomized, time series design.

SETTING: The urgent care clinic of a university-affiliated, county-supported hospital that provides care for underserved, vulnerable populations.

PATIENTS: Patients (N=2,189) who had a prescription written at the intervention site during the study.

INTERVENTION: Four-phase interventions lasting 2 weeks each, with a washout period between each phase, consisting of: (1) collection of baseline data utilizing the traditional prescription blank, (2) introduction of the pre-formatted prescription form, (3) use of the pre-formatted prescription form with medication cost added, and (4) pre-formatted prescription form with target drug (ranitidine) removed.

MEASUREMENTS AND MAIN RESULTS: Physicians were less likely to prescribe ranitidine compared to cimetidine after the introduction of the cost information (P<.01) and again after the removal of ranitidine from the pre-formatted prescription form (P<.001).

CONCLUSIONS: A structured, paper-based prescription order form can shift prescribing practices without inhibiting physicians’ ordering freedom.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Levit KR, Lazenby HC, Braden BR, and the National Health Accounts Team. National health spending trends in 1996. Health Aff. 1998;17:35–51.

    Article  CAS  Google Scholar 

  2. Iglehart JK. The American health care system: expenditures. N Engl J Med. 1999;340:70–6.

    Article  PubMed  CAS  Google Scholar 

  3. Hux JE, Melady MP, DeBoer D. Confidential prescriber feedback and education to improve antibiotic use in primary care: a controlled trial. CMAJ. 1999;161:388–92.

    PubMed  CAS  Google Scholar 

  4. Kong KM, Johnson WF, Anderson PO, Sato LA, Simonian RI. Effect of a pharmacy-based cost-containment program on cimetidine costs and use. Am J Hosp Pharm. 1987;44:2068–73.

    PubMed  CAS  Google Scholar 

  5. Algozzine GJ, Sprenger RL, Caselnova DA, Proper P. Pharmacy intern intervention to reduce costs associated with histamine H2-antagonist therapy. Am J Hosp Pharm. 1989;46:1183–84.

    PubMed  CAS  Google Scholar 

  6. Briceland LL, Lesar TS, Lomaestro BM, Lombardi TP, Gailey RA, Kowalsky SF. Streamlining antimicrobial therapy through pharmacists’ review of order sheets. Am J Hosp Pharm. 1989;46:1376–80.

    PubMed  CAS  Google Scholar 

  7. Raisch DW, Bootman JL, Larson LN, McGhan WF. Improving antiulcer agent prescribing in a health maintenance organization. Am J Hosp Pharm. 1990;47:1766–73.

    PubMed  CAS  Google Scholar 

  8. Falbe WJ, Bess DT, Capers CC, Haymond JD, Stahl AA. Effect of a criteria-based cost-containment program on the selection of oral H2-receptor antagonists. Am J Hosp Pharm. 1992;49:632–3.

    PubMed  CAS  Google Scholar 

  9. Brufsky JW, Ross-Degnan D, Calabrese D, Gao X, Soumerai SB. Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization. Med Care. 1998; 36:321–32.

    Article  PubMed  CAS  Google Scholar 

  10. Hasty M, Schrager J, Wrenin K. Physicians’ perceptions about managed care restrictions on antibiotic prescribing. J Gen Intern Med. 1999;14:756–8.

    Article  PubMed  CAS  Google Scholar 

  11. Sbarbaro JA. Can we influence prescribing patterns? Clin Infect Dis. 2001;33(Suppl 3):240–4.

    Article  Google Scholar 

  12. Evans RS, Classen DC, Pestotnik SL, Clemmer TP, Weaver LK, Burke JP. A decision support tool for antibiotic therapy. In: Proc Annu Symp Comput Appl Med Care. 1995;651–5.

  13. Shojania KG, Yokoe D, Platt R, Fiskio J, Ma’luf N, Bates D. Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial. J Am Med Inform Assoc. 1998;5:554–62.

    PubMed  CAS  Google Scholar 

  14. Rawlings RD. Therapeutic exchange of cefotaxime for ceftriaxone: evaluation, implementation, and subsequent cost savings at a 300-bed community hospital. Diagn Microbiol Infect Dis. 1995;22:235–37.

    Article  PubMed  CAS  Google Scholar 

  15. Chase SL, Peterson AM, Wordell CJ. Therapeutic-interchange program for oral histamine H2-receptor antagonists. Am J Health Syst Pharm. 1998;55:1382–6.

    PubMed  CAS  Google Scholar 

  16. Roth EJ, Plastaras CT, Mullin MS, Fillmore J, Moses ML. A simple institutional intervention to decrease use of selected expensive medications. Arch Phys Med Rehabil. 2001;82:633–6.

    Article  PubMed  CAS  Google Scholar 

  17. California Code of Regulations. Title 16, Division 17, Section 1717.3.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey J. Guterman MD, MS.

Additional information

Posthumous.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guterman, J.J., Chernof, B.A., Mares, B. et al. Modifying provider behavior. J GEN INTERN MED 17, 792–796 (2002). https://doi.org/10.1046/j.1525-1497.2002.20144.x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1046/j.1525-1497.2002.20144.x

Key words

Navigation